深圳招聘

Employment opportunities:

Hong Kong Epitherapeutics Limited. a new start up in Hong Kong focused on developing proprietary new DNA methylation based biomarkers of disease is seeking to fill up the following positions. We are looking for people who value perfection and are passionate and dedicated to developing new ideas and new products that make an impact and to grow with a new company at the cutting edge of technology. We are looking to fill up several positions immediately.

Responsibilities

• Perform experiments using molecular biology tools and next generation sequencing techniques under the regulation of lab standard operating procedures;
• Lead R&D and/or clinical trial projects;
• Optimize experiment workflow as needed;
• Conduct rational experiment design;
• Supervise junior researchers to perform experiments;
• Document experiment results and methodologies properly following standard operating procedures;
• Maintain lab equipment, lab area and supplies in a neat and professional manner;
• Report experiments to the lab manager.

Qualifications

• Doctorate degree in molecular biology, biochemistry or related fields;
• Experience in DNA and RNA preparations, conducting PCR and primer optimization;
• Knowledge of sequencing techniques is a plus;
• Skills in organization and time management;
• Able to work in a team under the guidance of senior staff.

We offer competitive salary, provident fund, medical package and 5-day work week. Candidates who are interested in the position should submit their full resume and cover letter.

All Personal data collected will be used for recruitment purpose only.

Career Level Middle level

Yr(s) of Exp 1 year experience

Qualification Postgraduate

Working language English

Company Industry Others

Job Function Sciences, Lab, R&D > Life Science

Employment Type Full Time

Others Recent Graduate will be considered

Benefits Five-day work week, Medical insurance, Transportation allowance

北京埃彼达雅医学诊断技术有限责任公司是一家专业从事表观遗传诊断及研发的新型尖端技术企业。公司专注于肿瘤、生物学年龄评估、自身免疫性疾病、精神类疾病等多种疾病的甲基化诊断技术的开发，已经成功研发出针对多种肿瘤的甲基化诊断技术，不仅可以有效超早期诊断肿瘤发生，还可以分期诊断肿瘤、评估治疗效果、辅助病理诊断。除此之外，公司还在甲基化诊断技术的基础上筛选药物靶点，开发相关抗癌、治疗疾病有效药物。

1. 超早期癌症DNA甲基化精准诊断技术

通过精准检测人体外周血细胞中DNA的甲基化修饰状态，高效评估并精确预测超早期癌症的发生风险，并精确评估肿瘤的发生、进展阶段以及治疗干预效果。

2. 生物学年龄甲基化诊断技术

通过对人体生物学年龄高度相关甲基化位点的检测，精确计算人体生物学年龄。

3. DHEA辅助戒毒技术

公司与北京高新医院合作研发脱氢表雄酮（DHEA）的附加治疗及其对表观遗传学标志物依赖的成瘾者生活质量和社会心理因素的影响试验。